Work

Treat-to-target in SLE: is serology important? Results from an integrated analysis of five randomized clinical trials of belimumab

Year: 2025

Type: article

Source: Lara D. Veeken

DOI: 10.1093/rheumatology/keaf107

Authors: Alvaro Gomez, Julius Lindblom, Ioannis Parodis, George Bertsias

Institutions: Karolinska University Hospital, Karolinska Institutet, Örebro University, University of Crete, FORTH Institute of Molecular Biology and Biotechnology, Foundation for Research and Technology Hellas

Language: English

Topic: Systemic Lupus Erythematosus Research

Subfield: Rheumatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: AstraZeneca, GlaxoSmithKline

OpenAlex ID: W4407857203

FWCI: 6.231

Cites: 50

Cited by: 10

Related to: 10